Literature DB >> 16105881

Non-Smad TGF-beta signals.

Aristidis Moustakas1, Carl-Henrik Heldin.   

Abstract

During the past 10 years, it has been firmly established that Smad pathways are central mediators of signals from the receptors for transforming growth factor beta (TGF-beta) superfamily members to the nucleus. However, growing biochemical and developmental evidence supports the notion that alternative, non-Smad pathways also participate in TGF-beta signalling. Non-Smad signalling proteins have three general mechanisms by which they contribute to physiological responses to TGF-beta: (1) non-Smad signalling pathways directly modify (e.g. phosphorylate) the Smads and thus modulate the activity of the central effectors; (2) Smads directly interact and modulate the activity of other signalling proteins (e.g. kinases), thus transmitting signals to other pathways; and (3) the TGF-beta receptors directly interact with or phosphorylate non-Smad proteins, thus initiating parallel signalling that cooperates with the Smad pathway in eliciting physiological responses. Thus, non-Smad signal transducers under the control of TGF-beta provide quantitative regulation of the signalling pathway, and serve as nodes for crosstalk with other major signalling pathways, such as tyrosine kinase, G-protein-coupled or cytokine receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105881     DOI: 10.1242/jcs.02554

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  461 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Pharmacological inhibition of TGFβ receptor improves Nkx2.5 cardiomyoblast-mediated regeneration.

Authors:  Wen-Pin Chen; Yuan-Hung Liu; Yi-Jin Ho; Sean M Wu
Journal:  Cardiovasc Res       Date:  2014-10-31       Impact factor: 10.787

Review 3.  Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment.

Authors:  Yubing Sun; Christopher S Chen; Jianping Fu
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

4.  TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.

Authors:  Samy Lamouille; Erin Connolly; James W Smyth; Rosemary J Akhurst; Rik Derynck
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

Review 5.  The pathogenesis of aortopathy in Marfan syndrome and related diseases.

Authors:  Jeffrey A Jones; John S Ikonomidis
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 6.  Roles for growth factors in cancer progression.

Authors:  Esther Witsch; Michael Sela; Yosef Yarden
Journal:  Physiology (Bethesda)       Date:  2010-04

Review 7.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

8.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

9.  Dendrite complexity of sympathetic neurons is controlled during postnatal development by BMP signaling.

Authors:  Afsaneh Majdazari; Jutta Stubbusch; Christian M Müller; Melanie Hennchen; Marlen Weber; Chu-Xia Deng; Yuji Mishina; Günther Schütz; Thomas Deller; Hermann Rohrer
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

Review 10.  Targeting the transforming growth factor-beta signaling pathway in human cancer.

Authors:  Nagathihalli S Nagaraj; Pran K Datta
Journal:  Expert Opin Investig Drugs       Date:  2010-01       Impact factor: 6.206

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.